ENDRA Life Sciences DSO Ratio 2011-2026 | NDRA

Annual DSO Ratio ENDRA Life Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	7.11	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
7.11	7.11	7.11

Quarterly DSO Ratio ENDRA Life Sciences

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	138	-	2.18	10.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
138	2.18	50.2

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Quest Diagnostics Incorporated DGX	44.9	$ 201.02	-1.01 %	$ 22.3 B	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	94.7	$ 3.93	-8.39 %	$ 5.23 M	USA
Fulgent Genetics FLGT	87	$ 18.54	-0.75 %	$ 571 M	USA
Castle Biosciences CSTL	50.2	$ 20.56	-0.68 %	$ 596 M	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	72.7	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Interpace Biosciences IDXG	66.9	$ 1.65	3.12 %	$ 7.3 M	USA
Illumina ILMN	66.8	$ 164.39	2.12 %	$ 25.5 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Guardant Health GH	46.1	$ 129.45	-1.65 %	$ 16.2 B	USA
CareDx, Inc CDNA	51.5	$ 22.98	0.04 %	$ 1.22 B	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
ICON Public Limited Company ICLR	63.4	$ 146.18	-	$ 11.5 B	Irlanda
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
NeoGenomics NEO	77.7	$ 11.09	-0.54 %	$ 1.42 B	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
National Research Corporation NRC	29.4	$ 18.35	-2.34 %	$ 411 M	USA
Natera NTRA	48.3	$ 214.4	1.1 %	$ 29.3 B	USA
Lantheus Holdings LNTH	80.5	$ 103.97	-0.53 %	$ 7.02 B	USA
Charles River Laboratories International CRL	65	$ 189.74	1.19 %	$ 9.4 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Pacific Biosciences of California PACB	71.8	$ 1.37	4.2 %	$ 411 M	USA
Medpace Holdings MEDP	50.4	$ 467.9	0.12 %	$ 13.5 B	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Mettler-Toledo International MTD	66.4	$ 1 142.32	0.96 %	$ 23.5 B	Schweiz
Myriad Genetics MYGN	52.3	$ 4.29	-0.92 %	$ 397 M	USA
Personalis PSNL	63.8	$ 9.8	2.19 %	$ 875 M	USA
Senseonics Holdings SENS	1.04	$ 7.28	1.35 %	$ 304 M	USA
Twist Bioscience Corporation TWST	44.5	$ 79.83	4.81 %	$ 4.77 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	27	-	-	$ 2.69 B	USA
Biomerica BMRA	57.7	$ 2.03	-1.22 %	$ 4.66 M	USA
Laboratory Corporation of America Holdings LH	52.9	$ 263.98	-0.82 %	$ 22 B	USA
Thermo Fisher Scientific TMO	70	$ 469.74	0.19 %	$ 177 B	USA
Trinity Biotech plc TRIB	87.2	$ 0.64	-1.51 %	$ 230 M	Irlanda
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	66.6	$ 9.13	0.33 %	$ 1.98 B	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA